Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Stancill JS, Corbett JA
GH Secretagogue Comparison Compound Class Receptor FDA Status Ipamorelin GHRP (ghrelin mimetic) GHS-R1a Not approved CJC-1295 GHRH analog GHRH-R Not approved Sermorelin GHRH analog GHRH-R Previously approved (Geref, discontinued) Tesamorelin GHRH analog GHRH-R FDA approved (Egrifta) GHRP-2 GHRP (ghrelin mimetic) GHS-R1a Not approved GHRP-6 GHRP (ghrelin mimetic) GHS-R1a Not approved Selectivity Profile: The Key Research Differentiator What makes Ipamorelin stand out among GHRPs is its endocrine selectivity
Goal and Experience Level Recovery peptides (BPC-157, TB-500) scale with injury severity
ICC critically revised the intellectual content of the review, and gave the final approval
The CJC-1295/Ipamorelin combo isnt magicbut it is science
Interested healthcare providers will need to submit a completed questionnaire to Empower for approval to order controlled substances for office-use.
